Nolato AB (publ)

PINK:NLTBF USA Medical Devices
Market Cap
$1.27 Billion
Market Cap Rank
#7811 Global
#4069 in USA
Share Price
$5.27
Change (1 day)
+0.00%
52-Week Range
$5.27 - $5.27
All Time High
$5.27
About

Nolato AB (publ) develops, manufactures, and sells plastic, silicone, and thermoplastic elastomer products in Europe, Asia, North America, and internationally. It operates through the Medical Solutions and Engineered Solutions segments. The company offers catheter balloons; breathing bags; non-conductive sealing and damping silicone products; primary plastic packaging for medicines; and crimp and… Read more

Nolato AB (publ) (NLTBF) - Net Assets

Latest net assets as of June 2025: $5.30 Billion USD

Based on the latest financial reports, Nolato AB (publ) (NLTBF) has net assets worth $5.30 Billion USD as of June 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($9.32 Billion) and total liabilities ($4.03 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $5.30 Billion
% of Total Assets 56.81%
Annual Growth Rate 10.61%
5-Year Change 55.12%
10-Year Change 226.21%
Growth Volatility 10.08

Nolato AB (publ) - Net Assets Trend (2002–2024)

This chart illustrates how Nolato AB (publ)'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Nolato AB (publ) (2002–2024)

The table below shows the annual net assets of Nolato AB (publ) from 2002 to 2024.

Year Net Assets Change
2024-12-31 $5.74 Billion +10.96%
2023-12-31 $5.17 Billion -4.10%
2022-12-31 $5.39 Billion +13.09%
2021-12-31 $4.77 Billion +28.90%
2020-12-31 $3.70 Billion +24.71%
2019-12-31 $2.97 Billion +14.43%
2018-12-31 $2.59 Billion +20.06%
2017-12-31 $2.16 Billion +16.70%
2016-12-31 $1.85 Billion +5.17%
2015-12-31 $1.76 Billion +12.25%
2014-12-31 $1.57 Billion +16.25%
2013-12-31 $1.35 Billion +11.87%
2012-12-31 $1.21 Billion +4.69%
2011-12-31 $1.15 Billion -2.37%
2010-12-31 $1.18 Billion +8.56%
2009-12-31 $1.09 Billion +2.65%
2008-12-31 $1.06 Billion +20.09%
2007-12-31 $881.00 Million +11.66%
2006-12-31 $789.00 Million -5.17%
2005-12-31 $832.00 Million +27.02%
2004-12-31 $655.00 Million +15.11%
2003-12-31 $569.00 Million -8.81%
2002-12-31 $624.00 Million --

Equity Component Analysis

This analysis shows how different components contribute to Nolato AB (publ)'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 7136.7% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings $4.34 Billion 75.67%
Common Stock $135.00 Million 2.35%
Other Comprehensive Income $773.00 Million 13.47%
Other Components $488.00 Million 8.50%
Total Equity $5.74 Billion 100.00%

Nolato AB (publ) Competitors by Market Cap

The table below lists competitors of Nolato AB (publ) ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Nolato AB (publ)'s equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 5,171,000,000 to 5,738,000,000, a change of 567,000,000 (11.0%).
  • Net income of 658,000,000 contributed positively to equity growth.
  • Dividend payments of 404,000,000 reduced retained earnings.
  • New share issuances of 7,000,000 increased equity.
  • Other comprehensive income increased equity by 318,000,000.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income $658.00 Million +11.47%
Dividends Paid $404.00 Million -7.04%
Share Issuances $7.00 Million +0.12%
Other Comprehensive Income $318.00 Million +5.54%
Other Changes $-12.00 Million -0.21%
Total Change $- 10.96%

Book Value vs Market Value Analysis

This analysis compares Nolato AB (publ)'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.25x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
  • The price-to-book ratio has decreased from 2.07x to 0.25x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2002-12-31 $2.55 $5.27 x
2003-12-31 $2.16 $5.27 x
2004-12-31 $2.49 $5.27 x
2005-12-31 $3.16 $5.27 x
2006-12-31 $3.00 $5.27 x
2007-12-31 $3.35 $5.27 x
2008-12-31 $4.02 $5.27 x
2009-12-31 $4.13 $5.27 x
2010-12-31 $4.48 $5.27 x
2011-12-31 $4.38 $5.27 x
2012-12-31 $4.58 $5.27 x
2013-12-31 $5.12 $5.27 x
2014-12-31 $5.96 $5.27 x
2015-12-31 $6.69 $5.27 x
2016-12-31 $7.03 $5.27 x
2017-12-31 $8.20 $5.27 x
2018-12-31 $9.82 $5.27 x
2019-12-31 $11.22 $5.27 x
2020-12-31 $13.88 $5.27 x
2021-12-31 $17.74 $5.27 x
2022-12-31 $20.02 $5.27 x
2023-12-31 $19.20 $5.27 x
2024-12-31 $21.30 $5.27 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Nolato AB (publ) utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 11.47%
  • The company shows good efficiency in utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 6.81%
  • • Asset Turnover: 1.00x
  • • Equity Multiplier: 1.69x
  • Recent ROE (11.47%) is below the historical average (17.32%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2002 9.62% 2.98% 1.06x 3.04x $-2.40 Million
2003 6.15% 1.31% 1.46x 3.22x $-21.90 Million
2004 19.85% 5.41% 1.50x 2.44x $64.50 Million
2005 21.75% 8.02% 1.35x 2.00x $97.80 Million
2006 6.08% 1.78% 1.57x 2.19x $-30.90 Million
2007 17.03% 6.20% 1.26x 2.18x $61.90 Million
2008 16.82% 6.30% 1.33x 2.01x $72.20 Million
2009 11.33% 4.73% 1.23x 1.95x $14.40 Million
2010 15.86% 5.54% 1.44x 1.99x $69.10 Million
2011 11.47% 4.43% 1.39x 1.86x $16.90 Million
2012 16.76% 5.21% 1.47x 2.19x $81.50 Million
2013 23.29% 6.94% 1.76x 1.91x $179.20 Million
2014 23.23% 8.60% 1.45x 1.86x $207.30 Million
2015 23.88% 8.89% 1.46x 1.84x $244.10 Million
2016 18.16% 7.56% 1.13x 2.12x $151.00 Million
2017 26.49% 8.51% 1.41x 2.20x $356.10 Million
2018 27.85% 8.91% 1.57x 1.99x $462.80 Million
2019 23.70% 8.88% 1.29x 2.07x $406.40 Million
2020 21.79% 8.61% 1.08x 2.35x $436.10 Million
2021 24.33% 9.99% 1.15x 2.11x $683.20 Million
2022 12.93% 6.47% 1.08x 1.86x $157.80 Million
2023 8.41% 4.56% 1.03x 1.80x $-82.10 Million
2024 11.47% 6.81% 1.00x 1.69x $84.20 Million

Industry Comparison

This section compares Nolato AB (publ)'s net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $694,749,556
  • Average return on equity (ROE) among peers: -25.46%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Nolato AB (publ) (NLTBF) $5.30 Billion 9.62% 0.76x $885.71 Million
Advanced Biomedical Technologies Inc (ABMT) $-4.46 Million 0.00% 0.00x $14.18K
Abbott Laboratories (ABT) $4.82 Billion 39.04% 1.31x $191.37 Billion
Acarix AB (publ) (ACIXF) $1.93 Million -127.02% 0.21x $26.42 Million
Adagio Medical Holdings, Inc Common Stock (ADGM) $-72.62 Million 0.00% 0.00x $4.05 Million
Adm Tronics Unltd (ADMT) $-12.69K 0.00% 0.00x $3.17 Million
Aethlon Medical Inc (AEMD) $-3.07 Million 0.00% 0.00x $2.79 Million
Acutus Medical Inc (AFIB) $126.58 Million -80.56% 0.52x $732.88K
Adapthealth Corp (AHCO) $2.07 Billion 7.56% 1.54x $914.25 Million
Allied Healthcare Products Inc. (AHPIQ) $8.88 Million -33.95% 1.22x $726.24
20/20 Biolabs, Inc. Common Stock (AIDX) $3.39 Million -59.65% 0.38x $9.18 Million